Tech Company Financing Transactions

Spinal Modulation Funding Round

Spinal Modulation secured a $30 million Series D funding round on 6/13/2011. Investors included De Novo Ventures, ePlanet Capital and InCube Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Medical Devices & Instruments

Mailing Address

1135 O'Brien Dr.
Menlo Park, CA 94025
USA

Phone

(650) 543-6800

Website

www.spinalmodulation.com

Email Address

[email protected]

Overview

The Spinal Modulation Axium Neurostimulator System is a next-generation intraspinal neuromodulation therapy that stimulates the dorsal root ganglion (DRG) to provide a new pain management option. It has shown promising results in managing chronic intractable leg pain, as well as difficult-to-target anatomy such as the back and foot.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

David Wood

        

Chief Scientific Officer

Jeff Kramer

        

Chief Technical Officer

Lynn Elliott

        

VP - Marketing

Dan Brounstein

        

VP - Operations

Bob Gaffney

        

VP - Regulatory Affairs

Steven McQuillan

        

VP - Sales

Martin Chambers

        

Browse more venture capital transactions:

Prev: 6/13/2011: Agrivida venture capital transaction
Next: 6/13/2011: Proterra venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to record every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary